SoumyaDChakravartyMDPhD, FACP, FACR
Rheumatology • Horsham, PASenior Director, Strategic Lead, Rheumatology Medical Affairs
Dr. Chakravarty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Ridgeview Drive
Horsham, PA 19044
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Rheumatology, 2010 - 2014- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2008 - 2010
Albert Einstein College of MedicineClass of 2008, MD, PhD
Certifications & Licensure
HI State Medical License 2024 - 2026
NY State Medical License 2009 - 2026
PA State Medical License 2013 - 2026
NJ State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Recipient, Scientist Development Award Rheumatology Research Foundation, 2012-2014
Publications & Presentations
PubMed
- Comparison of On-Label Treatment Persistence in Real-World Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Interleukin-17A Inhibitors.Philip J Mease, Shannon A Ferrante, Natalie J Shiff, Timothy P Fitzgerald, Soumya D Chakravarty
Advances in Therapy. 2025-02-01 - 1 citationsPersistent Patient-Level Effect of Guselkumab at Consecutive 8-Week Dosing Visits and Over Time in Patients With Active Psoriatic Arthritis: Post Hoc Analysis of a 2-Y...Philip J Mease, Xenofon Baraliakos, Vinod Chandran, Enrique R Soriano, Peter Nash
ACR Open Rheumatology. 2024-12-01 - 2 citationsComparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.Jessica A Walsh, Iris Lin, Ruizhi Zhao, Natalie J Shiff, Laura Morrison
Drugs - Real World Outcomes. 2024-09-01
Professional Memberships
- Fellow
- Fellow
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
